Stay updated on Denosumab + PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.

Latest updates to the Denosumab + PD-1 in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedMinor version update: revision v3.4.2 added and v3.4.1 removed, with no user-visible content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to trial content or page layout.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; no changes to study details, eligibility criteria, endpoints, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now shows a consolidated Locations section listing New Hampshire and North Carolina as study sites, replacing the previous separate location entries. The revision is updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedThe government funding status notice has been removed from the page. The remaining content appears unchanged.SummaryDifference0.3%

Stay in the know with updates to Denosumab + PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.